Filed 26d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Vertex Pharmaceuticals
VRTX
$15K+
Trade dateMay 8, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–55 of 55
Filed 2mo ago· Apr 3, 2026
10 days to disclose
Kevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMar 24, 2026
Common Stock
⚑ Pharmaceutical
Filed 4mo ago· Feb 2, 2026
4 days to disclose
David J. Taylor
RHouseOhio-02
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
-
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day window
Julia Letlow
RHouseLouisiana-05
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−9.1% vs S&P 500
Trade dateOct 23, 2024
-
Filed 8mo ago· Sep 12, 2025
36 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
BioNTech
BNTX
$1K-$15K
+15.1% vs S&P 500
Trade dateAug 7, 2025
Shares
Filed 9mo ago· Sep 2, 2025
26 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−2.9% vs S&P 500
Trade dateAug 7, 2025
-
Filed 9mo ago· Aug 13, 2025
57 days to disclose · 12 past 45-day window
Lisa C. McClain
RHouseMichigan-09
↓sold
Neurocrine Biosciences
NBIX
$1K-$15K
+11.3% vs S&P 500
Trade dateJun 17, 2025
Common Stock
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
63 days to disclose · 18 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+9.4% vs S&P 500
Trade dateJun 11, 2025
-
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
63 days to disclose · 18 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Neurocrine Biosciences
NBIX
$1K-$15K
+10.9% vs S&P 500
Trade dateJun 11, 2025
Common Stock
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
64 days to disclose · 19 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+9.5% vs S&P 500
Trade dateJun 10, 2025
-
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
245 days to disclose · 200 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−14.5% vs S&P 500
Trade dateDec 11, 2024
-
⚑ Pharmaceutical
Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Vertex Pharmaceuticals
VRTX
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
-
Filed 1.1y ago· Apr 14, 2025
25 days to disclose
Byron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
Filed 1.1y ago· Apr 11, 2025
29 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Vertex Pharmaceuticals
VRTX
$15K-$50K
−19.4% vs S&P 500
Trade dateMar 13, 2025
-
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Vertex Pharmaceuticals
VRTX
$15K-$50K
−13.1% vs S&P 500
Trade dateFeb 24, 2025
-
Filed 1.7y ago· Oct 3, 2024
30 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↓sold
BioNTech
BNTX
$1K-$15K
−5.3% vs S&P 500
Trade dateSep 3, 2024
Shares
Filed 1.7y ago· Sep 11, 2024
12 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
BioNTech
BNTX
$1K-$15K
−5.5% vs S&P 500
Trade dateAug 30, 2024
Shares
Filed 1.8y ago· Aug 6, 2024
403 days to disclose · 358 past 45-day window
David P. Joyce
RHouseOhio-14
↓sold
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$15K-$50K
+11.9% vs S&P 500
Trade dateJun 30, 2023
ETF
Filed 2.0y ago· Jun 14, 2024
37 days to disclose
Tommy Tuberville
RSenateAlabama
↑bought
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$1K-$15K
+11.5% vs S&P 500
Trade dateMay 8, 2024
S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
37 days to discloseTommy Tuberville
RSenateAlabama
↑bought
S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024
XBI
$1K-$15K
+11.5% vs S&P 500
Trade dateMay 8, 2024
Option⚑ Pharmaceutical
Filed 2.0y ago· Jun 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+32.4% vs S&P 500
Trade dateMay 3, 2024
⚑ Pharmaceutical
Filed 2.0y ago· Jun 8, 2024
29 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 10, 2024
Common Stock
Filed 2.1y ago· May 15, 2024
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
BioNTech
BNTX
$1K-$15K
−1.2% vs S&P 500
Trade dateApr 15, 2024
Shares
Filed 2.2y ago· Apr 7, 2024
24 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
BioNTech
BNTX
$1K-$15K
+1.8% vs S&P 500
Trade dateMar 14, 2024
Shares
Filed 2.2y ago· Mar 7, 2024
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateFeb 1, 2024
Common Stock
Filed 2.3y ago· Feb 11, 2024
40 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateJan 2, 2024
Common Stock
⚑ Pharmaceutical
Filed 2.4y ago· Jan 7, 2024
31 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
BioNTech
BNTX
$1K-$15K
−21.3% vs S&P 500
Trade dateDec 7, 2023
Shares
Filed 2.4y ago· Jan 7, 2024
32 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
BioNTech
BNTX
$1K-$15K
−20.6% vs S&P 500
Trade dateDec 6, 2023
Shares
Filed 2.4y ago· Jan 7, 2024
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
BioNTech
BNTX
$1K-$15K
−18.3% vs S&P 500
Trade dateDec 5, 2023
Shares
Filed 2.5y ago· Dec 8, 2023
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateNov 13, 2023
Filed 2.6y ago· Nov 11, 2023
26 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateOct 16, 2023
Filed 2.6y ago· Nov 9, 2023
16 days to disclose
Greg Stanton
DHouseArizona-04
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+16.3% vs S&P 500
Trade dateOct 24, 2023
Filed 2.6y ago· Oct 15, 2023
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateSep 15, 2023
Filed 3.0y ago· Jun 11, 2023
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 1, 2023
Filed 3.0y ago· May 19, 2023
39 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Mirati Therapeutics, Inc
MRTX
$1K-$15K
Trade dateApr 10, 2023
Mirati Therapeutics
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Karuna Therapeutics, Inc
KRTX
$1K-$15K
Trade dateApr 10, 2023
Karuna Therapeutics
Filed 3.1y ago· Apr 17, 2023
17 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Mirati Therapeutics, Inc
MRTX
$1K-$15K
Trade dateMar 31, 2023
Mirati Therapeutics
Filed 3.3y ago· Feb 17, 2023
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateJan 20, 2023
Filed 3.3y ago· Feb 14, 2023
14 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateJan 31, 2023
⚑ Pharmaceutical
Filed 3.4y ago· Jan 13, 2023
25 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$50K-$100K
Trade dateDec 19, 2022
⚑ Pharmaceutical
Filed 3.5y ago· Dec 16, 2022
43 days to disclose
Susan M. Collins
RSenateMaine
↑bought
Biogen
BIIB
$15K-$50K
Trade dateNov 3, 2022
Bond⚑ Pharmaceutical
Filed 3.6y ago· Nov 10, 2022
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−47.2% vs S&P 500
Trade dateOct 6, 2022
⚑ Pharmaceutical
Filed 3.9y ago· Jul 28, 2022
42 days to disclose
Christopher L. Jacobs
RHouseNew York-27
↑bought
Axsome Therapeutics
AXSM
$15K-$50K
+900.3% vs S&P 500
Trade dateJun 16, 2022
Filed 4.0y ago· Jun 14, 2022
29 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 16, 2022
⚑ Pharmaceutical
Filed 4.1y ago· May 5, 2022
37 days to disclose
William R. Keating
DHouseMassachusetts-09
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
+55.8% vs S&P 500
Trade dateMar 29, 2022
Filed 4.8y ago· Aug 26, 2021
213 days to disclose · 168 past 45-day window
Tom Malinowski
—HouseNew Jersey-07
↑bought
Pacira Biosciences
PCRX
$1K-$15K
Trade dateJan 25, 2021
Filed 4.8y ago· Aug 26, 2021
818 days to disclose · 773 past 45-day windowTom Malinowski
—HouseNew Jersey-07
↑bought
Pacira Biosciences
PCRX
$15K-$50K
Trade dateMay 31, 2019
Filed 4.9y ago· Jul 15, 2021
42 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateJun 3, 2021
Filed 4.9y ago· Jun 23, 2021
48 days to disclose · 3 past 45-day windowTom Malinowski
—HouseNew Jersey-07
↑bought
Pacira Biosciences
PCRX
$1K-$15K
−131.5% vs S&P 500
Trade dateMay 6, 2021
Filed 5.0y ago· Jun 15, 2021
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 20, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 15, 2021
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 20, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 15, 2021
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 20, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 15, 2021
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Exact Sciences
EXAS
$50K-$100K
Trade dateMay 20, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 12, 2021
53 days to disclose · 8 past 45-day windowTom Malinowski
—HouseNew Jersey-07
↑bought
Pacira Biosciences
PCRX
$1K-$15K
Trade dateApr 20, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 8, 2026 26d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Vertex Pharmaceuticals VRTX | May 8, 2026 | price pending | $15K+ midpoint $15K |
Apr 3, 2026 2mo ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS Common Stock ⚑ Pharmaceutical · Ways and Means | Mar 24, 2026 10 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Vertex Pharmaceuticals VRTX - | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Vertex Pharmaceuticals VRTX - | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Bad buy·−$826-10.3% −9.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | BioNTech BNTX Shares | Aug 7, 2025 36 days to disclose | Flat·+0.0% +15.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Vertex Pharmaceuticals VRTX - | Aug 7, 2025 26 days to disclose | Good buy·+$977+12.2% −2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Neurocrine Biosciences NBIX Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Flat·+0.0% +11.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 11, 2025 63 days to disclose · 18 past 45-day window | Flat·+0.0% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Neurocrine Biosciences NBIX Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 11, 2025 63 days to disclose · 18 past 45-day window | Good buy·+$1.6K+20.3% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 10, 2025 64 days to disclose · 19 past 45-day window | Flat·+0.0% +9.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 11, 2024 245 days to disclose · 200 past 45-day window | Bad buy·−$799-10.0% −14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Vertex Pharmaceuticals VRTX - | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Mar 13, 2025 29 days to disclose | Bad buy·−$5.3K-16.2% −19.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Feb 24, 2025 13 days to disclose | Bad buy·−$4.1K-12.5% −13.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 3, 2024 1.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | BioNTech BNTX Shares | Sep 3, 2024 30 days to disclose | Flat·+0.0% −5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2024 1.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | BioNTech BNTX Shares | Aug 30, 2024 12 days to disclose | Flat·+0.0% −5.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 6, 2024 1.8y ago | David P. Joyce RHouseOhio-14 | ↓sold | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI ETF | Jun 30, 2023 403 days to disclose · 358 past 45-day window | Flat·+0.0% +11.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI S&P Biotech SPDR Option Type: Call Strike price: $100.00 Expires: 10/18/2024 Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Good buy·+$4K+49.6% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↑bought | S&P Biotech SPDR Option Type: Put Strike price: $90.00 Expires: 10/18/2024 XBI Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 8, 2024 37 days to disclose | Good buy·+$4K+49.6% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 14, 2024 2.0y ago | Tommy Tuberville RSenateAlabama | ↓sold | Vertex Pharmaceuticals VRTX ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | May 3, 2024 42 days to disclose | Missed gain·−$583-7.3% +32.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 8, 2024 2.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS Common Stock | May 10, 2024 29 days to disclose | price pending | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | BioNTech BNTX Shares | Apr 15, 2024 30 days to disclose | Good buy·+$478+6.0% −1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2024 2.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | BioNTech BNTX Shares | Mar 14, 2024 24 days to disclose | Flat·+0.0% +1.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2024 2.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS Common Stock | Feb 1, 2024 35 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 11, 2024 2.3y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS Common Stock ⚑ Pharmaceutical · Ways and Means | Jan 2, 2024 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 7, 2024 2.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | BioNTech BNTX Shares | Dec 7, 2023 31 days to disclose | Bad buy·−$690-8.6% −21.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 7, 2024 2.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | BioNTech BNTX Shares | Dec 6, 2023 32 days to disclose | Bad buy·−$647-8.1% −20.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 7, 2024 2.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | BioNTech BNTX Shares | Dec 5, 2023 33 days to disclose | Bad buy·−$454-5.7% −18.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS | Nov 13, 2023 25 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 11, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Exact Sciences EXAS | Oct 16, 2023 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 9, 2023 2.6y ago | Greg Stanton DHouseArizona-04 | ↓sold | Vertex Pharmaceuticals VRTX | Oct 24, 2023 16 days to disclose | Flat·+0.0% +16.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 15, 2023 2.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS | Sep 15, 2023 30 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS | May 1, 2023 41 days to disclose | price pending | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Mirati Therapeutics MRTX Mirati Therapeutics | Apr 10, 2023 39 days to disclose | price pending | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Karuna Therapeutics KRTX Karuna Therapeutics | Apr 10, 2023 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Mirati Therapeutics MRTX Mirati Therapeutics | Mar 31, 2023 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 17, 2023 3.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Exact Sciences EXAS | Jan 20, 2023 28 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | Jan 31, 2023 14 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 13, 2023 3.4y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | Dec 19, 2022 25 days to disclose | price pending | $50K-$100K midpoint $75K |
Dec 16, 2022 3.5y ago | Susan M. Collins RSenateMaine | ↑bought | Biogen BIIB Bond⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 3, 2022 43 days to disclose | price pending | $15K-$50K midpoint $32.5K |
Nov 10, 2022 3.6y ago | Tommy Tuberville RSenateAlabama | ↑bought | Vertex Pharmaceuticals VRTX ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 6, 2022 35 days to disclose | Good buy·+$3.5K+44.1% −47.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 28, 2022 3.9y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Axsome Therapeutics AXSM | Jun 16, 2022 42 days to disclose | Good buy·+$300.3K+924.1% +900.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 14, 2022 4.0y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 16, 2022 29 days to disclose | price pending | $1K-$15K midpoint $8K |
May 5, 2022 4.1y ago | William R. Keating DHouseMassachusetts-09 | ↑bought | Vertex Pharmaceuticals VRTX | Mar 29, 2022 37 days to disclose | Good buy·+$5.1K+63.4% +55.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | Tom Malinowski —HouseNew Jersey-07 | ↑bought | Pacira Biosciences PCRX | Jan 25, 2021 213 days to disclose · 168 past 45-day window | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | Tom Malinowski —HouseNew Jersey-07 | ↑bought | Pacira Biosciences PCRX | May 31, 2019 818 days to disclose · 773 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Jul 15, 2021 4.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Exact Sciences EXAS | Jun 3, 2021 42 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 23, 2021 4.9y ago | Tom Malinowski —HouseNew Jersey-07 | ↑bought | Pacira Biosciences PCRX | May 6, 2021 48 days to disclose · 3 past 45-day window | Bad buy·−$4.9K-61.2% −131.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 20, 2021 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 20, 2021 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 20, 2021 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 20, 2021 26 days to disclose | price pending | $50K-$100K midpoint $75K |
Jun 12, 2021 5.0y ago | Tom Malinowski —HouseNew Jersey-07 | ↑bought | Pacira Biosciences PCRX | Apr 20, 2021 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |